# Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.

> **NCT02090439** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Departemental Vendee** · enrollment: 8 (actual)

## Conditions studied

- Kidney Stone
- Expulsive Medical Therapy

## Interventions

- **DRUG:** Silodosin

## Key facts

- **NCT ID:** NCT02090439
- **Lead sponsor:** Centre Hospitalier Departemental Vendee
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Following difficulties in patient recruitment, we were forced to stop the study prematurely.
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02090439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02090439, "Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT02090439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*